Market Exclusive

Analyst Activity – Canaccord Genuity Raises Its Price Target On Quest Diagnostics (NYSE:DGX) to $115.00

Analyst Ratings For Quest Diagnostics (NYSE:DGX)

Today, Canaccord Genuity raised its price target on Quest Diagnostics (NYSE:DGX) to $115.00 per share.

Some recent analyst ratings include

Dividend information for Quest Diagnostics (NYSE:DGX)

Quest Diagnostics (NYSE:DGX) pays an annual dividend of $1.80 with a yield of 1.73% and an average dividend growth of 11.70% based on a 3 Year Average..

Dividend History for Quest Diagnostics (NYSE:DGX)

Recent Insider Trading Activity For Quest Diagnostics (NYSE:DGX)
Quest Diagnostics (NYSE:DGX) has insider ownership of 1.75% and institutional ownership of 88.59%.

Recent Trading Activity for Quest Diagnostics (NYSE:DGX)
Shares of Quest Diagnostics closed the previous trading session at 103.85 down -0.50 0.48% with 227752 shares trading hands.

Exit mobile version